GGrantIndex
← Search

INHALED HUMAN INSULIN VS USUAL SUBCUTANEOUS HUMAN INSULIN THERAPY IN NIDDM

$22,433M01FY2000RRNIH

University Of New Mexico, Albuquerque NM

Investigators

Linked publications & trials

Abstract

The purpose of this pilot study is to collect data to determine whether glycemic control can be achieved at least as effectively with an insulin regimen involving pre-meal inhaled insulin plus a single bedtime Ultralente injection as with a conventional subcutaneous insulin regimen involving 2-3 injections per day.

View original record on NIH RePORTER →